Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma
Publication in refereed journal

Full Text

Times Cited
Web of Science487WOS source URL (as at 28/05/2020) Click here for the latest count

Other information
AbstractUsing real-time quantitative PCR, cell-free EBV DNA was detectable in the plasma of 96% (55 of 57) of nasopharyngeal carcinoma (NPC) patients (median concentration, 21058 copies/ml) and 7% (3 of 43) of controls (median concentration, 0 copies/ml), Advanced-stage NPC patients had higher plasma EBV DNA levels than those with early-stage disease, At I month after completion of radiotherapy, plasma EBV DNA was undetectable in 7 of 15 subjects (47%) but remained high in the remaining 8 subjects (53%). Clinical examination revealed that all of the former seven subjects had complete tumor regression, whereas six of the eight latter subjects exhibited evidence of disease persistence or had developed distant metastases. These results suggest that quantitative analysis of plasma EBV DNA may he a useful clinical and research tool in the screening and monitoring of NPC patients.
All Author(s) ListLo YMD, Chan LYS, Lo KW, Leung SF, Zhang J, Chan ATC, Lee JCK, Hjelm NM, Johnson PJ, Huang DP
Journal nameCancer Research
Volume Number59
Issue Number6
Pages1188 - 1191
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-29-05 at 02:54